Eli Lilly and Co – Page 2 – Finance Tailwind

Obesity pills from Eli Lilly, Novo Nordisk near US launch

Trump administration has backup plans for tariffs

Tariffs at U.S. Supreme Court might be start of a long battle

Stocks making the biggest moves midday: SATS, BF.A, SMTC, OKL

Stoxx 600, FTSE, DAX, data

Eli Lilly weight loss pill orforglipron clears trial, paving way for approval

Eli Lilly’s obesity pill will rival Novo Nordisk’s oral Wegovy drug

The price is REIT: CNBC’s UK Exchange newsletter

FDA approves Signos glucose monitoring for weight loss

Viking Therapeutics falls 30% on drug data